METROPOLIS HEALTHC (METROPOLIS.NS) Financials
METROPOLIS.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 15.1 billion | 4.6 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 15.0 billion | 5.1 billion |
METROPOLIS.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 499.8 million | ? |
| 2023-09-30 | 444.8 million | ? |
| 2023-06-30 | 416.4 million | ? |
| 2023-03-31 | 468.7 million | ? |
METROPOLIS.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 271.6 million |
| 2023-09-30 | 354.5 million |
| 2023-06-30 | 288.0 million |
| 2023-03-31 | 333.6 million |
METROPOLIS.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 1.2 billion | 1.2 billion | 1.9 billion |
| 2023-06-30 | - | - | - |
| 2023-03-31 | 1.2 billion | 1.5 billion | 1.9 billion |
METROPOLIS.NS Shares Outstanding
METROPOLIS.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 282.1 million | - | 697.5 million | - |
| 2023-06-30 | - | - | 650.6 million | - |
| 2023-03-31 | 526.3 million | - | 643.1 million | - |
METROPOLIS.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.9 billion | 593.4 million |
| 2023-09-30 | 3.1 billion | 640.8 million |
| 2023-06-30 | 2.8 billion | 593.8 million |
| 2023-03-31 | 2.8 billion | 598.4 million |
METROPOLIS.NS
Price: ₹1,838.20
Dividend Yield: 0.00%
Forward Dividend Yield: 0.22%
Payout Ratio: 16.72%
Dividend Per Share: 4.00 INR
Earnings Per Share: 24.35 INR
P/E Ratio: 68.53
Exchange: NSI
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 92.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 4